Computational imaging reveals mitochondrial morphology as a biomarker of cancer phenotype and drug response.

In both the case of ABT-263 and cisplatin, we observed highly heterogeneous responses to the drug treatments, illustrating the need for population level analyses as completed here when analyzing the effects of drugs on mitochondrial morphology, as such heterogeneity may be significant in determining overall tumor response to treatment.

also in 13,097 other papers